Stay updated on Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Sign up to get notified when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.

Latest updates to the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new revision entry v3.3.2 is added to the Record History and the previous entry v3.3.1 is removed.SummaryDifference0.1%

- Check15 days agoChange DetectedThe Record History now includes a new revision entry v3.3.1 and removes the older revision v3.2.0; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check22 days agoChange DetectedThe government operating status notice at the top of the page was removed, and the rest of the study history content remains unchanged.SummaryDifference0.7%

- Check36 days agoChange DetectedThe updates reflect minor visual and layout adjustments to the Record History page and the version list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedMajor update: alerts about government funding status and a new version v3.2.0. Deletion of v3.1.0 indicates the version refresh.SummaryDifference12%

- Check72 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.